Abstract:Corticobasal degeneration (CBD) is a neurodegenerative disease characterized by asymmetric motor symptoms and cerebral cortical dysfunction, with pathological diagnosis as gold standard. Due to the heterogeneity of clinical features and the overlapping with other neurodegenerative diseases in symptoms and pathology, the diagnosis of CBD is difficult. The correct rate of current diagnostic criteria is low and the imaging is excluded. In this paper, we give a review of the progress in imaging of CBD in recent decades, including computed tomography (CT), magnetic resonance imaging (MRI), radionuclide imaging, and their contributions in identification of CBD with other diseases.
